Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool
- PMID: 20444706
- PMCID: PMC2898425
- DOI: 10.1074/jbc.M109.084434
Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool
Abstract
Huntington disease is caused by expanded polyglutamine sequences in huntingtin, which procures its aggregation into intracellular inclusion bodies (IBs). Aggregate intermediates, such as soluble oligomers, are predicted to be toxic to cells, yet because of a lack of quantitative methods, the kinetics of aggregation in cells remains poorly understood. We used sedimentation velocity analysis to define and compare the heterogeneity and flux of purified huntingtin with huntingtin expressed in mammalian cells under non-denaturing conditions. Non-pathogenic huntingtin remained as hydrodynamically elongated monomers in vitro and in cells. Purified polyglutamine-expanded pathogenic huntingtin formed elongated monomers (2.4 S) that evolved into a heterogeneous aggregate population of increasing size over time (100-6,000 S). However, in cells, mutant huntingtin formed three major populations: monomers (2.3 S), oligomers (mode s(20,w) = 140 S) and IBs (mode s(20,w) = 320,000 S). Strikingly, the oligomers did not change in size heterogeneity or in their proportion of total huntingtin over 3 days despite continued monomer conversion to IBs, suggesting that oligomers are rate-limiting intermediates to IB formation. We also determined how a chaperone known to modulate huntingtin toxicity, Hsc70, influences in-cell huntingtin partitioning. Hsc70 decreased the pool of 140 S oligomers but increased the overall flux of monomers to IBs, suggesting that Hsc70 reduces toxicity by facilitating transfer of oligomers into IBs. Together, our data suggest that huntingtin aggregation is streamlined in cells and is consistent with the 140 S oligomers, which remain invariant over time, as a constant source of toxicity to cells irrespective of total load of insoluble aggregates.
Figures





Similar articles
-
Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.J Biol Chem. 2012 May 4;287(19):16017-28. doi: 10.1074/jbc.M111.252577. Epub 2012 Mar 20. J Biol Chem. 2012. PMID: 22433867 Free PMC article.
-
Formation and toxicity of soluble polyglutamine oligomers in living cells.PLoS One. 2010 Dec 28;5(12):e15245. doi: 10.1371/journal.pone.0015245. PLoS One. 2010. PMID: 21209946 Free PMC article.
-
Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein.J Biol Chem. 2011 May 20;286(20):18320-30. doi: 10.1074/jbc.M110.199448. Epub 2011 Mar 30. J Biol Chem. 2011. PMID: 21454633 Free PMC article.
-
Aggregation of expanded huntingtin in the brains of patients with Huntington disease.Prion. 2007 Jan-Mar;1(1):26-31. doi: 10.4161/pri.1.1.4056. Prion. 2007. PMID: 19172113 Free PMC article. Review.
-
Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.Essays Biochem. 2014;56:167-80. doi: 10.1042/bse0560167. Essays Biochem. 2014. PMID: 25131594 Review.
Cited by
-
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging.PLoS One. 2012;7(9):e44457. doi: 10.1371/journal.pone.0044457. Epub 2012 Sep 12. PLoS One. 2012. PMID: 22984513 Free PMC article.
-
Molecular interaction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1 modulates aggregation.J Biol Chem. 2015 Jan 30;290(5):2560-76. doi: 10.1074/jbc.M114.603332. Epub 2014 Dec 10. J Biol Chem. 2015. PMID: 25505179 Free PMC article.
-
Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.Front Neurosci. 2021 Feb 12;15:621996. doi: 10.3389/fnins.2021.621996. eCollection 2021. Front Neurosci. 2021. PMID: 33642983 Free PMC article. Review.
-
The Aggregation Free Energy Landscapes of Polyglutamine Repeats.J Am Chem Soc. 2016 Nov 23;138(46):15197-15203. doi: 10.1021/jacs.6b08665. Epub 2016 Nov 10. J Am Chem Soc. 2016. PMID: 27786478 Free PMC article.
-
Tracking protein aggregation and mislocalization in cells with flow cytometry.Nat Methods. 2012 Mar 18;9(5):467-70. doi: 10.1038/nmeth.1930. Nat Methods. 2012. PMID: 22426490
References
-
- Chiti F., Dobson C. M. (2006) Annu. Rev. Biochem. 75, 333–366 - PubMed
-
- Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G. P., Davies S. W., Lehrach H., Wanker E. E. (1997) Cell 90, 549–558 - PubMed
-
- Arrasate M., Mitra S., Schweitzer E. S., Segal M. R., Finkbeiner S. (2004) Nature 431, 805–810 - PubMed
-
- Takahashi Y., Okamoto Y., Popiel H. A., Fujikake N., Toda T., Kinjo M., Nagai Y. (2007) J. Biol. Chem. 282, 24039–24048 - PubMed
-
- Takahashi T., Kikuchi S., Katada S., Nagai Y., Nishizawa M., Onodera O. (2007) Hum. Mol. Genet. 17, 345–346 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous